Dorsey & Whitney Trust CO LLC Novo Nordisk A S Transaction History

Dorsey & Whitney Trust CO LLC

$1.81 Billion
Q3 2025

A detailed history of Dorsey & Whitney Trust CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dorsey & Whitney Trust CO LLC holds 28,869 shares of NVO stock, worth $1.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

28,869

Previous 29,591 2.44%

Holding current value

$1.4 Million

Previous $2.04 Million 21.6%

% of portfolio

0.09%

Previous 0.11%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$45.38 - $71.7 $32,764 - $51,767	-722 Reduced 2.44%	28,869 $1.6 Million
Q2 2025 Aug 11, 2025	SELL	$58.08 - $81.05 $55,466 - $77,402	-955 Reduced 3.13%	29,591 $2.04 Million
Q1 2025 May 14, 2025	SELL	$69.3 - $90.95 $65,696 - $86,220	-948 Reduced 3.01%	30,546 $2.12 Million
Q4 2024 Feb 07, 2025	BUY	$85.0 - $120.04 $11,560 - $16,325	136 Added 0.43%	31,494 $2.71 Million
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $164,554 - $200,970	1,382 Added 4.61%	31,358 $3.73 Million

Q2 2024 Aug 07, 2024	SELL	$122.71 - $146.91 $213,392 - $255,476	-1,739 Reduced 5.48%	29,976 $4.28 Million
Q1 2024 May 09, 2024	BUY	$102.11 - $135.92 $34,615 - $46,076	339 Added 1.08%	31,715 $4.07 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $100,244 - $120,423	1,142 Added 3.78%	31,376 $3.25 Million
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $1.37 Million - $3.01 Million	15,077 Added 99.47%	30,234 $2.75 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $118,232 - $130,868	758 Added 5.26%	15,157 $2.45 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $19,453 - $23,393	147 Added 1.03%	14,399 $2.29 Million
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $148,800 - $196,363	1,451 Added 11.34%	14,252 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $24,486 - $30,051	257 Added 2.05%	12,801 $1.28 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $32,933 - $38,857	319 Added 2.61%	12,544 $1.4 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $72,152 - $87,218	775 Added 6.77%	12,225 $1.36 Million
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $33,462 - $40,860	349 Added 3.14%	11,450 $1.28 Million
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $928 - $1,172	-11 Reduced 0.1%	11,101 $1.07 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $3,180 - $3,983	47 Added 0.42%	11,112 $930,000
Q1 2021 May 11, 2021	BUY	$67.06 - $75.82 $44,192 - $49,965	659 Added 6.33%	11,065 $746,000
Q4 2020 Feb 05, 2021	BUY	$63.89 - $73.8 $1,725 - $1,992	27 Added 0.26%	10,406 $727,000
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $573 - $631	9 Added 0.09%	10,379 $720,000
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $1,170 - $1,358	20 Added 0.19%	10,370 $680,000
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $7,666 - $10,040	-155 Reduced 1.48%	10,350 $624,000
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $99 - $116	-2 Reduced 0.02%	10,505 $606,000
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $9,175 - $10,311	-193 Reduced 1.8%	10,507 $543,000
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $2,199 - $2,466	47 Added 0.44%	10,700 $546,000
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $182,009 - $206,625	3,926 Added 58.36%	10,653 $557,000
Q4 2018 Jan 25, 2019	BUY	$41.54 - $47.25 $17,446 - $19,845	420 Added 6.66%	6,727 $310,000
Q3 2018 Oct 26, 2018	BUY	$46.76 - $51.24 $34,929 - $38,276	747 Added 13.44%	6,307 $297,000
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $1,993 - $2,268	-45 Reduced 0.8%	5,560 $257,000
Q1 2018 May 08, 2018	SELL	$48.49 - $58.14 $8,097 - $9,709	-167 Reduced 2.89%	5,605 $276,000
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $274,343 - $310,129	5,772	5,772 $310,000

Others Institutions Holding NVO

# of Institutions

1,684

Shares Held

304M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.

Account

Dorsey & Whitney Trust CO LLC Novo Nordisk A S Transaction History